U.S. Real-World Evidence (RWE) Solutions Market Worth $2.01 billion by 2028 - Exclusive Report by Meticulous Research®
February 15, 2022 08:03 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Feb. 15, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled “U.S. Real-World Evidence Solutions Market by Component [Datasets (Clinical, Claims,...
Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results
February 10, 2022 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Microdose Psychedelics Presents a Molecular Masterclass: The LSD Conference
February 10, 2022 09:35 ET
|
Microdose Psychedelic Insights
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- via PsychedelicNewsWire -- Microdose Psychedelic Insights, a cutting-edge conference production company focused on promoting content, financial analysis...
Mydecine’s Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in Canada
February 08, 2022 07:30 ET
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to...
SV Investment and Orange Grove Bio Establish Partnership to Jointly Source and Develop Novel Therapeutics in the U.S. and Korea
February 08, 2022 07:00 ET
|
Orange Grove Bio
Collaboration will Focus on Identifying Most Promising Research Emerging from Biotech Companies in Korea and U.S. for Licensing, Investment and Company Creation Partnership Supports Orange Grove’s...
Outlook on the Structural Biology & Molecular Modeling Techniques Global Market to 2027 - Featuring Acellera, Agenus and Illumina Among Others
February 03, 2022 07:48 ET
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Structural Biology & Molecular Modeling Techniques Market Research Report by Tools, by Application, by Region - Global Forecast to 2027 -...
Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member
February 03, 2022 07:30 ET
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to...
Worldwide Optical Preclinical Imaging Industry to 2027 - Rising Number of Public-private Initiatives and Funding to Support Preclinical Researches Presents Opportunities
February 02, 2022 09:03 ET
|
Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Optical Preclinical Imaging Market Research Report by Product Type, by End-use, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19"...
Global Clinical Research Services Market Research Report (2021 to 2027) - by Services, Indication, Deployment, End-user and Region
February 02, 2022 08:58 ET
|
Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Clinical Research Services Market Research Report by Services, by Indication, by Deployment, by End User, by Region - Global Forecast to 2027 -...
Mydecine Submits Pre-Investigational New Drug Briefing Package to the FDA for MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial
February 01, 2022 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology and digital technology company aiming to...